Equities
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)162.80
  • Today's Change1.00 / 0.62%
  • Shares traded84.69k
  • 1 Year change+34.99%
  • Beta1.2853
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments594441311
Total Receivables, Net386265207
Total Inventory437305237
Prepaid expenses302019
Other current assets, total------
Total current assets1,4471,031774
Property, plant & equipment, net284162128
Goodwill, net2,391794741
Intangibles, net755308313
Long term investments232114
Note receivable - long term------
Other long term assets------
Total assets4,9312,3391,992
LIABILITIES
Accounts payable985756
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases332523
Other current liabilities, total574335234
Total current liabilities705417313
Total long term debt226192180
Total debt259217203
Deferred income tax1937173
Minority interest------
Other liabilities, total1502255
Total liabilities1,274702621
SHAREHOLDERS EQUITY
Common stock1129392
Additional paid-in capital2,291281266
Retained earnings (accumulated deficit)1,3781,2291,063
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(124)34(50)
Total equity3,6571,6371,371
Total liabilities & shareholders' equity4,9312,3391,992
Total common shares outstanding806666
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.